187 related articles for article (PubMed ID: 7761856)
1. Stable transfection of malaria parasite blood stages.
van Dijk MR; Waters AP; Janse CJ
Science; 1995 Jun; 268(5215):1358-62. PubMed ID: 7761856
[TBL] [Abstract][Full Text] [Related]
2. Expression of a Plasmodium gene introduced into subtelomeric regions of Plasmodium berghei chromosomes.
van Dijk MR; Janse CJ; Waters AP
Science; 1996 Feb; 271(5249):662-5. PubMed ID: 8571132
[TBL] [Abstract][Full Text] [Related]
3. The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome.
de Koning-Ward TF; Fidock DA; Thathy V; Menard R; van Spaendonk RM; Waters AP; Janse CJ
Mol Biochem Parasitol; 2000 Mar; 106(2):199-212. PubMed ID: 10699250
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of pyrimethamine resistance in two different strains of Plasmodium berghei.
van Dijk MR; McConkey GA; Vinkenoog R; Waters AP; Janse CJ
Mol Biochem Parasitol; 1994 Nov; 68(1):167-71. PubMed ID: 7891743
[No Abstract] [Full Text] [Related]
5. Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.
Jongco AM; Ting LM; Thathy V; Mota MM; Kim K
Mol Biochem Parasitol; 2006 Apr; 146(2):242-50. PubMed ID: 16458371
[TBL] [Abstract][Full Text] [Related]
6. Gene targeting in the rodent malaria parasite Plasmodium yoelii.
Mota MM; Thathy V; Nussenzweig RS; Nussenzweig V
Mol Biochem Parasitol; 2001 Apr; 113(2):271-8. PubMed ID: 11295181
[TBL] [Abstract][Full Text] [Related]
7. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei.
Janse CJ; Ramesar J; Waters AP
Nat Protoc; 2006; 1(1):346-56. PubMed ID: 17406255
[TBL] [Abstract][Full Text] [Related]
8. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine.
Wu Y; Kirkman LA; Wellems TE
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1130-4. PubMed ID: 8577727
[TBL] [Abstract][Full Text] [Related]
9. Replication, expression and segregation of plasmid-borne DNA in genetically transformed malaria parasites.
van Dijk MR; Vinkenoog R; Ramesar J; Vervenne RA; Waters AP; Janse CJ
Mol Biochem Parasitol; 1997 Jun; 86(2):155-62. PubMed ID: 9200122
[TBL] [Abstract][Full Text] [Related]
10. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
[TBL] [Abstract][Full Text] [Related]
11. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria.
Peterson DS; Walliker D; Wellems TE
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9114-8. PubMed ID: 2904149
[TBL] [Abstract][Full Text] [Related]
12. Heterologous expression of active thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum.
Sirawaraporn W; Sirawaraporn R; Cowman AF; Yuthavong Y; Santi DV
Biochemistry; 1990 Dec; 29(48):10779-85. PubMed ID: 2176883
[TBL] [Abstract][Full Text] [Related]
13. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum.
Cowman AF; Morry MJ; Biggs BA; Cross GA; Foote SJ
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9109-13. PubMed ID: 3057499
[TBL] [Abstract][Full Text] [Related]
14. Studies of Plasmodium falciparum dihydrofolate-reductase thymidylate synthase: potential advantages.
Inselburg J; Bzik DJ; Gu H; Li WB; Horii T
Prog Clin Biol Res; 1989; 313():29-43. PubMed ID: 2675115
[No Abstract] [Full Text] [Related]
15. Stable transformation of Toxoplasma gondii based on a pyrimethamine resistant trifunctional dihydrofolate reductase-cytosine deaminase-thymidylate synthase gene that confers sensitivity to 5-fluorocytosine.
Fox BA; Belperron AA; Bzik DJ
Mol Biochem Parasitol; 1999 Jan; 98(1):93-103. PubMed ID: 10029312
[TBL] [Abstract][Full Text] [Related]
16. Toxoplasma gondii: generation of novel truncation mutations in the linker domain of dihydrofolate reductase-thymidylate synthase.
Belperron AA; Fox BA; O'Neil RH; Peaslee KA; Horii T; Anderson AC; Bzik DJ
Exp Parasitol; 2004; 106(3-4):179-82. PubMed ID: 15172226
[No Abstract] [Full Text] [Related]
17. Complementation of Plasmodium berghei TRAP knockout parasites using human dihydrofolate reductase gene as a selectable marker.
Sultan AA; Thathy V; de Koning-Ward TF; Nussenzweig V
Mol Biochem Parasitol; 2001 Mar; 113(1):151-6. PubMed ID: 11254963
[TBL] [Abstract][Full Text] [Related]
18. Virulence and drug resistance in malaria parasites.
Stein WD; Sanchez CP; Lanzer M
Trends Parasitol; 2009 Oct; 25(10):441-3. PubMed ID: 19734096
[TBL] [Abstract][Full Text] [Related]
19. Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes.
Ménard R; Sultan AA; Cortes C; Altszuler R; van Dijk MR; Janse CJ; Waters AP; Nussenzweig RS; Nussenzweig V
Nature; 1997 Jan; 385(6614):336-40. PubMed ID: 9002517
[TBL] [Abstract][Full Text] [Related]
20. Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria.
Donald RG; Roos DS
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11703-7. PubMed ID: 8265612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
